Status:
COMPLETED
Measuring Oxygenation of Newborn Infants in Targeted Oxygen Ranges
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
NHS Lothian
Conditions:
Premature Infant
Hypoxia
Eligibility:
All Genders
48-1 years
Phase:
NA
Brief Summary
The investigators aim to measure the effect of targeting premature babies to a slightly higher oxygen saturation target range (92-97%) than routinely used, for a brief period, to plan a future larger ...
Detailed Description
This study is a single centre randomised crossover study. Infants born at less than 29 weeks gestation, greater than 48 hours of age and receiving supplementary oxygen would be eligible for inclusion....
Eligibility Criteria
Inclusion
- Infants born at less than 29 weeks gestation
- Infants greater than 48 hours of age
- Infants who are receiving supplementary oxygen
Exclusion
- Congenital anomalies that would affect oxygenation (eg. cardiac defects, congenital diaphragmatic hernia)
Key Trial Info
Start Date :
January 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 17 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03360292
Start Date
January 18 2020
End Date
February 17 2022
Last Update
March 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neonatal Unit - Royal Infirmary of Edinburgh
Edinburgh, Lothian, United Kingdom, EH16 4SA